Metabolic health and strategies for a Healthier SG.
10.4103/singaporemedj.SMJ-2025-157
- Author:
Joan KHOO
1
;
Rachel Li Cui LIM
2
;
Lok Pui NG
2
;
Ian Kwong Yun PHOON
2
;
Linsey GANI
1
;
Troy Hai Kiat PUAR
1
;
Choon How HOW
3
;
Wann Jia LOH
1
Author Information
1. Department of Endocrinology, Changi General Hospital, Singapore.
2. SingHealth Polyclinics, Singapore.
3. Duke-NUS Medical School, Singapore.
- Publication Type:Review
- Keywords:
Diabetes mellitus;
dyslipdaemia;
hypertension;
metabolic syndrome;
obesity
- MeSH:
Humans;
Singapore;
Diabetes Mellitus, Type 2/therapy*;
Hypertension/therapy*;
Obesity/therapy*;
Dyslipidemias/therapy*;
Telemedicine;
Cardiovascular Diseases/prevention & control*;
Exercise;
Metabolic Diseases/prevention & control*
- From:Singapore medical journal
2025;66(Suppl 1):S30-S37
- CountrySingapore
- Language:English
-
Abstract:
This review examines strategies for the prevention and management of obesity, hypertension, type 2 diabetes mellitus and dyslipidaemia, conditions that are increasing in Singapore, as components of individualised health plans in 'Healthier SG' and beyond. We describe cardiometabolic disease prevention and management initiatives in Changi General Hospital (CGH), including collaborations with SingHealth Polyclinics, Active SG, Exercise is Medicine Singapore and community partners in the Eastern Community Health Outreach programme, and highlight advances in curable hypertension (e.g., primary hyperaldosteronism) and novel cardiovascular risk markers such as lipoprotein(a). We also outline technology-based interventions, notably the CGH Health Management Unit, which demonstrate the utility and convenience of telemedicine, and digital therapeutics in the form of apps that have been shown to improve treatment adherence and clinical outcomes. Individual empowerment, in partnership with community and healthcare providers and supported by research and innovation of care delivery, is key to building a healthier and stronger nation.
